Clinical Trials Directory

Trials / Sponsors / Lynk Pharmaceuticals Co., Ltd

Lynk Pharmaceuticals Co., Ltd

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Ankylosing Spondylitis
Phase 32025-08-29
CompletedA Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis
Atopic Dermatitis
Phase 22025-03-18
CompletedA Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
Atopic Dermatitis
Phase 32024-02-06
Active Not RecruitingA Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
Rheumatoid Arthritis
Phase 32023-12-12
CompletedSafety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.
Atopic Dermatitis
Phase 12023-07-12
CompletedA Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 22022-01-26
CompletedA Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
Ankylosing Spondylitis
Phase 22022-01-06
CompletedA Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 22021-11-18
WithdrawnA Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leu
Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis
Phase 12021-04-08